Fizy Health routes cash-pay clinic and telehealth orders to assigned LegitScript-certified 503A compounding partners for therapies like GLP-1, hormones, and peptides. The platform is ordering software, not a compounding pharmacy: clinics browse one aggregated formulary, build a patient-linked clinic cart, validate SIG and prescriber licensure before payment, checkout once, and let multi-pharmacy routing send each line to the correct 503A partner with pass-through per-vial pricing visible before submit.
Evaluating 503A scope, partner coverage, and routing? This page explains what Fizy Health orders, what compounders fulfill, and how lines split after checkout.
Clinics prescribe across partners and states. Compounders compound and ship. Fizy Health owns the software path between prescriber intent and the right 503A fill without clinics living in five compounder portals.
Operators evaluate 503A ordering on partner coverage, rejection rate before payment, checkout efficiency across partners, and tracking visibility per patient line.
GLP-1, hormone, peptide, and related compounded SKUs from every assigned LegitScript-certified partner appear in one searchable catalog with pass-through landed cost on each line.
Formulary discovery without logging into each compounder separately.
Validation on SIG, prescriber licensure, and stock reduces paid orders that 503A partners bounce back for fixable errors. Clinics protect margin and patient trust on high-volume days.
Fewer post-payment compounder rejections.
Multi-pharmacy routing splits the clinic cart after one payment so staff never manually assign compounder per line or re-enter patients in partner-specific portals.
Partner assignment handled in software, not on a spreadsheet.
Resolved per-vial pharmacy cost appears before checkout with disclosed software facilitation fee. Owners see 503A economics separate from platform software charges.
Per-vial numbers aligned from quote through fulfillment.
Here is how a compounded order moves from clinic cart to LegitScript-certified 503A partner fill on Fizy Health.
Search compounded therapies across assigned partners. Pass-through landed cost displays on each SKU before the line enters the cart.
Each cart row links to a patient with SIG and shipping context required for 503A fulfillment.
SIG rules, prescriber licensure against patient state, and stock checks run before payment.
Single payment covers pass-through pharmacy lines plus disclosed facilitation fee. Staff do not pay each compounder separately.
Each line submits to the correct LegitScript-certified compounder. Status and tracking return to the platform per patient line.
Understanding 503A boundaries keeps clinics evaluating the right outcomes: partner coverage, validation quality, routing accuracy, and pricing visibility on compounded therapies.
503A therapies
Fizy Health supports cash-pay clinic ordering for common 503A categories including GLP-1, hormone, peptide, and related compounded protocols assigned on your formulary. Specific SKU coverage depends on partner assignment during onboarding.
LegitScript partners
Orders fulfill through assigned LegitScript-certified 503A partners. Formulation quality, certificates of analysis, and fill timelines are partner responsibilities. Fizy Health coordinates order submission and tracking software.
Not 503B retail
Fizy Health focuses on clinic workflows that tie each order line to a patient for 503A fulfillment. Office-use bulk models outside patient-linked ordering are a different procurement pattern.
Software boundary
The platform does not replace 503A pharmacy licenses. It validates, prices, routes, and tracks patient-linked orders to partners that compound and ship.
Your clinic prescribes compounded therapies from 503A partners regularly.
Your medication mix does not include patient-specific 503A compounded orders.
503A ordering with HIPAA alignment, BAA, and audit trails on patient-linked lines
These surfaces are how clinics move 503A volume from catalog through validation to partner fulfillment on Fizy Health.
Medication catalog aggregates assigned compounder formularies with pass-through landed cost.
Pass-through pricing resolves pharmacy landed cost on each compounded line before payment.
New starts and refills for every patient share one cart and one checkout session.
Cart validation on SIG, licensure, and stock before checkout reduces downstream rejects.
Multi-pharmacy routing submits lines to correct LegitScript-certified partners after one payment.
Fizy Health supports patient-linked compounded orders routed to assigned LegitScript-certified 503A partners, commonly including GLP-1, hormone, peptide, and related cash-pay therapies on your formulary. Specific SKU availability depends on partner assignment confirmed during onboarding.
Orders route to assigned LegitScript-certified 503A compounding partners on your clinic formulary. Partner list and SKU coverage are confirmed during onboarding. Fizy Health coordinates submission and tracking; partners compound and ship.
Staff checkout once for the whole clinic cart. Multi-pharmacy routing sends each line to the correct assigned 503A partner automatically based on formulary rules. Staff do not manually split payments per compounder.
Pass-through pricing displays resolved per-vial 503A landed cost in catalog and cart before checkout. A disclosed software facilitation fee applies at payment based on organization plan tier.
Cart validation checks SIG, prescriber licensure against patient shipping context, and stock availability before payment. That reduces orders 503A partners would reject after checkout.
No. Fizy Health is software that routes orders to LegitScript-certified 503A partners. Compounding, quality, and shipping are partner pharmacy responsibilities. Questions about formulation belong to those partners.
Start free with pass-through pricing and validation before checkout. Route compounded lines to LegitScript-certified partners in one session.